GE Healthcare Launches Four New Affinity Chromatography Media for Production of Antibody Fragments and other Biopharmaceuticals

Piscataway, NJ, November 3, 2008 - GE Healthcare has launched four new custom-designed BioProcess affinity chromatography media for industrial-scale purifications of various biopharmaceuticals, including antibodies, antibody fragments and Adeno Associated Virus (AAV). The new media have been developed as part of GE Healthcare’s Custom-Design Media program and enable the rapid one-step purification of biopharmaceuticals with [...]

Japan’s Leading National Institute Orders World’s Most Powerful Microscope from FEI

Advanced technology drives selection over entrenched competition at one of world's premier research institutions JEJU ISLAND, South Korea, Nov 03, 2008 -- FEI Company (Nasdaq:FEIC), a leading provider of high-resolution imaging and analysis systems, today announced the selection of its Titan(3(TM)) 80-300 scanning/transmission electron microscope (S/TEM) by the National Institute for Materials Science (NIMS), Japan's [...]

Fluxion Biosciences Expands European Network with Distributor for UK, Ireland and France

Labtech International Ltd to Distribute BioFlux Line of Live Cell Imaging Products San Francisco, Calif. (November 3, 2008) - Fluxion Biosciences announced today an exclusive distribution agreement with East Sussex, UK-based Labtech International Ltd. Labtech will handle sales and service in the UK, Ireland and France of Fluxion's BioFlux research tools for live cell image [...]

FEI Adds Dual-Axis Automation to Leading Electron Tomography Solution for Life Science Research

Xplore3D now offers automated dual-axis acquisition and reconstruction¡ªextending the capability and accuracy of electron tomography for 3D biological ultrastructure Hillsboro, Ore./November 3, 2008¡ªFEI Company (Nasdaq: FEIC), a leading provider of high-resolution imaging and analysis solutions, today released its Xplore3D software package, updated to include data acquisition and reconstruction for dual-axis electron tomography. The new capability [...]

Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month

Private community fosters separation scientist interactions and provides premium content not found elsewhere MILFORD, Mass., Nov. 3 -- Waters Corporation (NYSE: WAT - News) today reports on the successful debut of an online community designed to support the success of new and advanced ACQUITY UPLC® chromatographers. Created especially for Waters® ACQUITY UltraPerformance LC® (UPLC) System [...]

Source MDx Announces Partnership with Brigham and Women’s Hospital to Study RNA-Based Biomarkers for Multiple Sclerosis

Source MDx today announced a partnership with Brigham and Women's Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers [...]

FEI’s New TrueCrystal Package Provides Rapid, Accurate Strain Profiling for Semiconductor Manufacturing

Automated strain analysis package combines ease of use with reduced time to data Hillsboro, Ore./November 3, 2008¯FEI Company (Nasdaq: FEIC), a leading provider of atomic-scale imaging and analysis systems, today released its new TrueCrystal Strain Analysis package that can be installed on a Titan™ or Tecnai™ scanning/transmission electron microscope (S/TEM) system. The new, automated strain [...]

Celera Appoints Scott K. Milsten as General Counsel

Celera (NASDAQ:CRA) today announced the appointment of Scott K. Milsten as Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Milsten will report to Kathy Ordonez, Celera's Chief Executive Officer. Mr. Milsten was most recently Deputy General Counsel for Gen-Probe Incorporated (NASDAQ:GPRO). In this capacity, he managed corporate governance and securities compliance, and structured [...]

Tripos International Completes Acquisition of Pharsight Corporation

Tripos International, the leading provider of drug discovery informatics products and services, today announced that it has completed the acquisition of Pharsight Corporation, a leader in software, strategic and regulatory services designed to optimize clinical drug development. The transaction, valued at approximately $57 million, moves Pharsight into the Tripos portfolio. In making the announcement, Tripos' [...]

Source MDx Announces Partnership with Brigham and Women’s Hospital to Study RNA-Based Biomarkers for Multiple Sclerosis

Source MDx today announced a partnership with Brigham and Women's Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers [...]

Access IBO on Knowledge Center